Register entry

Arbor Pharmaceuticals, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
6
Live patents
6
Countries
0
Catalogue

Drug listings by form and route

6

6 active NDC listings: 6 human prescription drug. By marketing category: ANDA 6.

Dosage formNDCs
tablet, delayed release3
tablet, film coated2
capsule, delayed release1
RouteNDCs
oral6
Labeller name on the listingNDCs
arbor pharmaceuticals, inc.6
Exclusivity

Patents and exclusivities

6
PatentProductCoversExpiry
8747894CETYLEVacetylcysteineproductMay 2032
9427421CETYLEVacetylcysteineproductMay 2032
9561204CETYLEVacetylcysteineuseMay 2032
Catalogue

Marketed products

6
BrandGeneric nameForm / routeNDC
ERY-TABErythromycintablet, delayed release, oral24338-122ANDA
ERY-TABErythromycintablet, delayed release, oral24338-124ANDA
ERY-TABErythromycintablet, delayed release, oral24338-126ANDA
ERYTHROMYCINErythromycincapsule, delayed release, oral24338-120ANDA
ErythromycinErythromycintablet, film coated, oral24338-102ANDA
ErythromycinErythromycintablet, film coated, oral24338-104ANDA
Compare

Other companies listing erythromycin

Enquiry

Common questions

Is Arbor Pharmaceuticals, Inc. FDA approved?
Arbor Pharmaceuticals, Inc. holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Arbor Pharmaceuticals, Inc. make?
6 products are listed under Arbor Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as tablet, delayed release; tablet, film coated; capsule, delayed release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.